resveratrol has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Chen, CF; Cheng, CY; Huang, YS; Li, IH; Ma, KH; Pao, LH; Shih, JH; Shiue, CY; Weng, SJ; Yeh, MK | 1 |
1 review(s) available for resveratrol and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
1 other study(ies) available for resveratrol and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Evaluation of brain SERT occupancy by resveratrol against MDMA-induced neurobiological and behavioral changes in rats: A 4-[¹⁸F]-ADAM/small-animal PET study.
Topics: Animals; Benzylamines; Brain; Brain Mapping; Corticosterone; Depressive Disorder; Dose-Response Relationship, Drug; Fluorine Radioisotopes; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neuroprotective Agents; Positron-Emission Tomography; Radiopharmaceuticals; Random Allocation; Rats, Sprague-Dawley; Resveratrol; RNA-Binding Proteins; Serotonin Agents; Stilbenes | 2016 |